A possible mechanism for maintenance of the deleterious allele of human CASPASE-12

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 803-806

  Hermel, Evan ^a   Klapstein, Kevin D ^a  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 12; GENE PRODUCT;

ARTICLE; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; NONHUMAN;

ALLELES; CASPASE 12; HUMANS;

BACTERIA (MICROORGANISMS);

EID: 80053968249     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.041     Document Type: Article

References (52)

1. Moffitt K.L., Martin S.L., Walker B. From sentencing to execution-the processes of apoptosis. J Pharm Pharmacol 2010, 62:547-562.
2. Lamkanfi M., Festjens N., Declercq W., Vanden Berghe T., Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 2007, 14:44-55.
3. Chowdhury I., Tharakan B., Bhat G.K. Caspases - an update. Comp Biochem Physiol B Biochem Mol Biol 2008, 151:10-27.
4. Nunez G., Benedict M.A., Hu Y., Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene 1998, 17:3237-3245.
5. Barrett A.J., Rawlings N.D. Evolutionary lines of cysteine peptidases. Biol Chem 2001, 382:727-733.
6. Kersse K., Vanden Berghe T., Lamkanfi M., Vandenabeele P. A phylogenetic and functional overview of inflammatory caspases and caspase-1-related CARD-only proteins. Biochem Soc Trans 2007, 35:1508-1511.
7. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999, 15:269-290.
8. Bilsland J., Harper S. Caspases and neuroprotection. Curr Opin Investig Drugs 2002, 3:1745-1752.
9. Hermel E., Hart A.J., Gunduz I., Acton H., Kim C., Wurth M., et al. Polymorphism and conservation of the genes encoding Qa1 molecules. Immunogenetics 2004, 56:639-649.
10. Wellington C.L., Ellerby L.M., Gutekunst C.A., Rogers D., Warby S., Graham R.K., et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci 2002, 22:7862-7872.
11. Saleh M., Vaillancourt J.P., Graham R.K., Huyck M., Srinivasula S.M., Alnemri E.S., et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004, 429:75-79.
12. Kachapati K., O'Brien T.R., Bergeron J., Zhang M., Dean M. Population distribution of the functional caspase-12 allele. Hum Mutat 2006, 27:975.
13. Fischer H., Koenig U., Eckhart L., Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun 2002, 293:722-726.
14. Roy S., Sharom J.R., Houde C., Loisel T.P., Vaillancourt J.P., Shao W., et al. Confinement of caspase-12 proteolytic activity to autoprocessing. Proc Natl Acad Sci U S A 2008, 105:4133-4138.
15. Xue Y., Daly A., Yngvadottir B., Liu M., Coop G., Kim Y., et al. Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am J Hum Genet 2006, 78:659-670.
16. Scott A.M., Saleh M. The inflammatory caspases: guardians against infections and sepsis. Cell Death Differ 2007, 14:23-31.
17. Wang X., Grus W.E., Zhang J. Gene losses during human origins. PLoS Biol 2006, 4:e52.
18. Rao R.V., Hermel E., Castro-Obregon S., del Rio G., Ellerby L.M., Ellerby H.M., et al. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem 2001, 276:33869-33874.
19. Rao R.V., Peel A., Logvinova A., del Rio G., Hermel E., Yokota T., et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 2002, 514:122-128.
20. LeBlanc P.M., Yeretssian G., Rutherford N., Doiron K., Nadiri A., Zhu L., et al. Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe 2008, 3:146-157.
21. Saleh M., Mathison J.C., Wolinski M.K., Bensinger S.J., Fitzgerald P., Droin N., et al. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006, 440:1064-1068.
22. Ferwerda B., McCall M.B., de Vries M.C., Hopman J., Maiga B., Dolo A., et al. Caspase-12 and the inflammatory response to Yersinia pestis. PLoS One 2009, 4:e6870.
23. McCall M.B., Ferwerda B., Hopman J., Ploemen I., Maiga B., Daou M., et al. Persistence of full-length caspase-12 and its relation to malaria in West and Central African populations. Eur Cytokine Netw 2010, 21:77-83.
24. Eckhart L., Ballaun C., Hermann M., VandeBerg J.L., Sipos W., Uthman A., et al. Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire. Mol Biol Evol 2008, 25:831-841.
25. Plantinga T.S., Hamza O.J., Willment J.A., Ferwerda B., Van de Geer N.M., Verweij P.E., et al. Genetic variation of innate immune genes in HIV-infected african patients with or without oropharyngeal candidiasis. J Acquir Immune Defic Syndr 2010, 55:87-94.
26. Labbe K., Miu J., Yeretssian G., Serghides L., Tam M., Finney C.A., et al. Caspase-12 Dampens the Immune Response to Malaria Independently of the Inflammasome by Targeting NF-{kappa}B Signaling. J Immunol 2010, 185:5495-5502.
27. Burki T. East African countries struggle with visceral leishmaniasis. Lancet 2009, 374:371-372.
28. Franchi L., Eigenbrod T., Munoz-Planillo R., Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009, 10:241-247.
29. Weiss D.S., Henry T., Monack D.M. Francisella tularensis: activation of the inflammasome. Ann NY Acad Sci 2007, 1105:219-237.
30. Yeretssian G., Doiron K., Shao W., Leavitt B.R., Hayden M.R., Nicholson D.W., et al. Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proc Natl Acad Sci U S A 2009, 106:9016-9020.
31. Liu N., Belperron A.A., Booth C.J., Bockenstedt L.K. The caspase 1 inflammasome is not required for control of murine Lyme borreliosis. Infect Immun 2009, 77:3320-3327.
32. O'Brien T.R., Kachapati K., Zhang M., Bergeron J., Edlin B.R., Dean M. HCV infection clearance with functional or non-functional caspase-12. Scand J Gastroenterol 2007, 42:416-417.
33. Yu H.B., Finlay B.B. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 2008, 4:198-208.
34. Naik E., Dixit V.M. Modulation of inflammasome activity for the treatment of auto-inflammatory disorders. J Clin Immunol 2010, 30:485-490.
35. Thylefors B., Negrel A.D., Pararajasegaram R., Dadzie K.Y. Global data on blindness. Bull World Health Organ 1995, 73:115-121.
36. Bebear C., De Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect 2009, 15:4-10.
37. Hvid M., Baczynska A., Deleuran B., Fedder J., Knudsen H.J., Christiansen G., et al. Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol 2007, 9:2795-2803.
38. Burton M.J., Mabey D.C. The global burden of trachoma: a review. PLoS Negl Trop Dis 2009, 3:e460.
39. White J.A. Manifestations and management of lymphogranuloma venereum. Curr Opin Infect Dis 2009, 22:57-66.
40. Prantner D., Darville T., Sikes J.D., Andrews C.W., Brade H., Rank R.G., et al. Critical role for interleukin-1beta (IL-1beta) during Chlamydia muridarum genital infection and bacterial replication-independent secretion of IL-1beta in mouse macrophages. Infect Immun 2009, 77:5334-5346.
41. Hu V.H., Harding-Esch E.M., Burton M.J., Bailey R.L., Kadimpeul J., Mabey D.C. Epidemiology and control of trachoma: systematic review. Trop Med Int Health 2010, 15:673-691.
42. Laga M. Epidemiology and control of sexually transmitted diseases in developing countries. Sex Transm Dis 1994, 21:S45-50.
43. Guiney D.G. The role of host cell death in Salmonella infections. Curr Top Microbiol Immunol 2005, 289:131-150.
44. Monack D.M., Hersh D., Ghori N., Bouley D., Zychlinsky A., Falkow S. Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model. J Exp Med 2000, 192:249-258.
45. Mariathasan S., Newton K., Monack D.M., Vucic D., French D.M., Lee W.P., et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004, 430:213-218.
46. Brennan M.A., Cookson B.T. Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol 2000, 38:31-40.
47. Lara-Tejero M., Sutterwala F.S., Ogura Y., Grant E.P., Bertin J., Coyle A.J., et al. Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J Exp Med 2006, 203:1407-1412.
48. Morpeth S.C., Ramadhani H.O., Crump J.A. Invasive non-Typhi Salmonella disease in Africa. Clin Infect Dis 2009, 49:606-611.
49. van Marle G., Antony J., Ostermann H., Dunham C., Hunt T., Halliday W., et al. West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence. J Virol 2007, 81:10933-10949.
50. Wang P., Arjona A., Zhang Y., Sultana H., Dai J., Yang L., et al. Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat Immunol 2010, 11:912-919.
51. Pourrut X., Nkoghe D., Paweska J., Leroy E. First serological evidence of West Nile virus in human rural populations of Gabon. Virol J 2010, 7:132.
52. Haggerty C.L., Gottlieb S.L., Taylor B.D., Low N., Xu F., Ness R.B. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010, 201:S134-S155. Suppl 2.